We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Oncology Biosimilars industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
- mAb
- Immunomodulators
- Hematopoietic Agents
- G-CSF
- Others
Market Segment by Product Application
- Retail Pharmacies
- Hospital Pharmacy
- Online Pharmacy
Finally, the report provides detailed profile and data information analysis of leading company.
- Celltrion
- Teva Pharmaceutical Industries Ltd
- STADA Arzneimittel AG
- Biocon
- Sandoz International
- Dr. Reddy's Laboratories
- BIOCAD
- Pfizer
- Intas Pharmaceuticals
- Apotex
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
- 1.To study and analyze the global Oncology Biosimilars consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
- 2.To understand the structure of Oncology Biosimilars market by identifying its various subsegments.
- 3.Focuses on the key global Oncology Biosimilars manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
- 4.To analyze the Oncology Biosimilars with respect to individual growth trends, future prospects, and their contribution to the total market.
- 5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- 6.To project the consumption of Oncology Biosimilars submarkets, with respect to key regions (along with their respective key countries).
- 7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- 8.To strategically profile the key players and comprehensively analyze their growth strategies.
Global Oncology Biosimilars Professional Survey Report 2021, Forecast to 2026
Table of Contents
Global Oncology Biosimilars Professional Survey Report Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Oncology Biosimilars Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Oncology Biosimilars Segment by Type
2.1.1 mAb
2.1.2 Immunomodulators
2.1.3 Hematopoietic Agents
2.1.4 G-CSF
2.1.5 Others
2.2 Market Analysis by Application
2.2.1 Retail Pharmacies
2.2.2 Hospital Pharmacy
2.2.3 Online Pharmacy
2.3 Global Oncology Biosimilars Market Comparison by Regions (2016-2026)
2.3.1 Global Oncology Biosimilars Market Size (2016-2026)
2.3.2 North America Oncology Biosimilars Status and Prospect (2016-2026)
2.3.3 Europe Oncology Biosimilars Status and Prospect (2016-2026)
2.3.4 Asia-pacific Oncology Biosimilars Status and Prospect (2016-2026)
2.3.5 South America Oncology Biosimilars Status and Prospect (2016-2026)
2.3.6 Middle East & Africa Oncology Biosimilars Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Oncology Biosimilars Industry Impact
2.5.1 Oncology Biosimilars Business Impact Assessment - Covid-19
2.5.2 Market Trends and Oncology Biosimilars Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Oncology Biosimilars Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Oncology Biosimilars Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Oncology Biosimilars Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Oncology Biosimilars Manufacturer Market Share
3.5 Top 10 Oncology Biosimilars Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Oncology Biosimilars Market
3.7 Key Manufacturers Oncology Biosimilars Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Oncology Biosimilars Industry Key Manufacturers
4.1 Celltrion
4.1.1 Company Details
4.1.2 Celltrion Oncology Biosimilars Product Introduction, Application and Specification
4.1.3 Celltrion Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Celltrion News
4.2 Teva Pharmaceutical Industries Ltd
4.2.1 Company Details
4.2.2 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Product Introduction, Application and Specification
4.2.3 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Teva Pharmaceutical Industries Ltd News
4.3 STADA Arzneimittel AG
4.3.1 Company Details
4.3.2 STADA Arzneimittel AG Oncology Biosimilars Product Introduction, Application and Specification
4.3.3 STADA Arzneimittel AG Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 STADA Arzneimittel AG News
4.4 Biocon
4.4.1 Company Details
4.4.2 Biocon Oncology Biosimilars Product Introduction, Application and Specification
4.4.3 Biocon Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Biocon News
4.5 Sandoz International
4.5.1 Company Details
4.5.2 Sandoz International Oncology Biosimilars Product Introduction, Application and Specification
4.5.3 Sandoz International Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Sandoz International News
4.6 Dr. Reddy's Laboratories
4.6.1 Company Details
4.6.2 Dr. Reddy's Laboratories Oncology Biosimilars Product Introduction, Application and Specification
4.6.3 Dr. Reddy's Laboratories Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Dr. Reddy's Laboratories News
4.7 BIOCAD
4.7.1 Company Details
4.7.2 BIOCAD Oncology Biosimilars Product Introduction, Application and Specification
4.7.3 BIOCAD Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.5 BIOCAD News
4.8 Pfizer
4.8.1 Company Details
4.8.2 Pfizer Oncology Biosimilars Product Introduction, Application and Specification
4.8.3 Pfizer Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 Pfizer News
4.9 Intas Pharmaceuticals
4.9.1 Company Details
4.9.2 Intas Pharmaceuticals Oncology Biosimilars Product Introduction, Application and Specification
4.9.3 Intas Pharmaceuticals Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.9.4 Main Business Overview
4.9.5 Intas Pharmaceuticals News
4.10 Apotex
4.10.1 Company Details
4.10.2 Apotex Oncology Biosimilars Product Introduction, Application and Specification
4.10.3 Apotex Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.10.4 Main Business Overview
4.10.5 Apotex News
5 Global Oncology Biosimilars Sales Categorized by Regions
5.1 Global Oncology Biosimilars Revenue, Sales and Market Share by Regions
5.1.1 Global Oncology Biosimilars Sales and Market Share by Regions (2016-2021)
5.1.2 Global Oncology Biosimilars Revenue and Market Share by Regions (2016-2021)
5.2 North America Oncology Biosimilars Sales and Growth Rate (2016-2021)
5.3 Europe Oncology Biosimilars Sales and Growth Rate (2016-2021)
5.4 Asia-pacific Oncology Biosimilars Sales and Growth Rate (2016-2021)
5.5 South America Oncology Biosimilars Sales and Growth Rate (2016-2021)
5.6 Middle East & Africa Oncology Biosimilars Sales and Growth Rate (2016-2021)
6 North America Oncology Biosimilars Market Size Categorized by Countries
6.1 North America Oncology Biosimilars Sales, Revenue and Market Share by Countries
6.1.1 North America Oncology Biosimilars Sales (Volume) by Countries (2016-2021)
6.1.2 North America Oncology Biosimilars Revenue by Countries (2016-2021)
6.1.3 United States Oncology Biosimilars Sales and Growth Rate (2016-2021)
6.1.4 Canada Oncology Biosimilars Sales and Growth Rate (2016-2021)
6.1.5 Mexico Oncology Biosimilars Sales and Growth Rate (2016-2021)
6.2 North America Oncology Biosimilars Revenue (Value) by Manufacturers
6.3 North America Oncology Biosimilars Sales and Market Share by Type (2016-2021)
6.4 North America Oncology Biosimilars Sales Market Share by Application (2016-2021)
7 Europe Oncology Biosimilars Market Size Categorized by Countries
7.1 Europe Oncology Biosimilars Sales, Revenue and Market Share by Countries
7.1.1 Europe Oncology Biosimilars Sales (Volume) by Countries (2016-2021)
7.1.2 Europe Oncology Biosimilars Revenue by Countries (2016-2021)
7.1.3 Germany Oncology Biosimilars Sales and Growth Rate (2016-2021)
7.1.4 UK Oncology Biosimilars Sales and Growth Rate (2016-2021)
7.1.5 France Oncology Biosimilars Sales and Growth Rate (2016-2021)
7.1.6 Russia Oncology Biosimilars Sales and Growth Rate (2016-2021)
7.1.7 Italy Oncology Biosimilars Sales and Growth Rate (2016-2021)
7.1.8 Spain Oncology Biosimilars Sales and Growth Rate (2016-2021)
7.2 Europe Oncology Biosimilars Revenue (Value) by Manufacturers
7.3 Europe Oncology Biosimilars Sales and Market Share by Type (2016-2021)
7.4 Europe Oncology Biosimilars Sales Market Share by Application (2016-2021)
8 Asia-Pacific Oncology Biosimilars Market Size Categorized by Countries
8.1 Asia-pacific Oncology Biosimilars Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Oncology Biosimilars Sales (Volume) by Countries (2016-2021)
8.1.2 Asia-pacific Oncology Biosimilars Revenue by Countries (2016-2021)
8.1.3 China Oncology Biosimilars Sales and Growth Rate (2016-2021)
8.1.4 South Korea Oncology Biosimilars Sales and Growth Rate (2016-2021)
8.1.5 Japan Oncology Biosimilars Sales and Growth Rate (2016-2021)
8.1.6 Australia Oncology Biosimilars Sales and Growth Rate (2016-2021)
8.1.7 India Oncology Biosimilars Sales and Growth Rate (2016-2021)
8.1.8 Southeast Asia Oncology Biosimilars Sales and Growth Rate (2016-2021)
8.2 Asia-pacific Oncology Biosimilars Revenue (Value) by Manufacturers
8.3 Asia-pacific Oncology Biosimilars Sales and Market Share by Type (2016-2021)
8.4 Asia-pacific Oncology Biosimilars Sales Market Share by Application (2016-2021)
9 South America Oncology Biosimilars Market Size Categorized by Countries
9.1 South America Oncology Biosimilars Sales, Revenue and Market Share by Countries
9.1.1 South America Oncology Biosimilars Sales (Volume) by Countries (2016-2021)
9.1.2 South America Oncology Biosimilars Revenue by Countries (2016-2021)
9.1.3 Brazil Oncology Biosimilars Sales and Growth Rate (2016-2021)
9.2 South America Oncology Biosimilars Sales and Market Share by Type (2016-2021)
9.3 South America Oncology Biosimilars Sales Market Share by Application (2016-2021)
10 Middle East and Africa Oncology Biosimilars Market Size Categorized by Countries
10.1 Middle East and Africa Oncology Biosimilars Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Oncology Biosimilars Sales (Volume) by Countries (2016-2021)
10.1.2 Middle East and Africa Oncology Biosimilars Revenue by Countries (2016-2021)
10.1.3 GCC Countries Oncology Biosimilars Sales and Growth Rate (2016-2021)
10.1.4 Turkey Oncology Biosimilars Sales and Growth Rate (2016-2021)
10.1.5 Egypt Oncology Biosimilars Sales and Growth Rate (2016-2021)
10.1.6 South America Oncology Biosimilars Sales and Growth Rate (2016-2021)
10.2 Middle East and Africa Oncology Biosimilars Sales and Market Share by Type
10.3 Middle East and Africa Oncology Biosimilars Sales Market Share by Application (2016-2021)
11 Global Oncology Biosimilars Market Segment by Type
11.1 Global Oncology Biosimilars Revenue, Sales and Market Share by Type (2016-2021)
11.1.1 Global Oncology Biosimilars Sales and Market Share by Type (2016-2021)
11.1.2 Global Oncology Biosimilars Revenue and Market Share by Type (2016-2021)
11.2 mAb Sales Growth Rate and Price
11.2.1 Global mAb Sales Growth Rate (2016-2021)
11.2.2 Global mAb Price (2016-2021)
11.3 Immunomodulators Sales Growth Rate and Price
11.3.1 Global Immunomodulators Sales Growth Rate (2016-2021)
11.3.2 Global Immunomodulators Price (2016-2021)
11.4 Hematopoietic Agents Sales Growth Rate and Price
11.4.1 Global Hematopoietic Agents Sales Growth Rate (2016-2021)
11.4.2 Global Hematopoietic Agents Price (2016-2021)
11.5.1 Global G-CSF Sales Growth Rate (2016-2021)
11.5.2 Global G-CSF Price (2016-2021)
11.6 Others Sales Growth Rate and Price
11.6.1 Global Others Sales Growth Rate (2016-2021)
11.6.2 Global Others Price (2016-2021)
12 Global Oncology Biosimilars Market Segment by Application
12.1 Global Oncology Biosimilars Sales Market Share by Application (2016-2021)
12.2 Retail Pharmacies Sales Growth Rate (2016-2021)
12.3 Hospital Pharmacy Sales Growth Rate (2016-2021)
12.4 Online Pharmacy Sales Growth Rate (2016-2021)
13 Global Oncology Biosimilars Market Forecast
13.1 Global Oncology Biosimilars Revenue, Sales and Growth Rate (2021-2026)
13.2 Oncology Biosimilars Market Forecast by Regions (2021-2026)
13.2.1 North America Oncology Biosimilars Market Forecast (2021-2026)
13.2.2 Europe Oncology Biosimilars Market Forecast (2021-2026)
13.2.3 Asia-Pacific Oncology Biosimilars Market Forecast (2021-2026)
13.2.4 South America Oncology Biosimilars Market Forecast (2021-2026)
13.2.5 Middle East & Africa Oncology Biosimilars Market Forecast (2021-2026)
13.3 Oncology Biosimilars Market Forecast by Type (2021-2026)
13.3.1 Global Oncology Biosimilars Sales Forecast by Type (2021-2026)
13.3.2 Global Oncology Biosimilars Market Share Forecast by Type (2021-2026)
13.4 Oncology Biosimilars Market Forecast by Application (2021-2026)
13.4.1 Global Oncology Biosimilars Sales Forecast by Application (2021-2026)
13.4.2 Global Oncology Biosimilars Market Share Forecast by Application (2021-2026)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Oncology Biosimilars Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Oncology Biosimilars Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Oncology Biosimilars
Figure Market Concentration Ratio and Market Maturity Analysis of Oncology Biosimilars
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Oncology Biosimilars Market Size by Type
Figure Global Market Share of Oncology Biosimilars by Type in 2020
Figure mAb Picture
Figure Immunomodulators Picture
Figure Hematopoietic Agents Picture
Figure G-CSF Picture
Figure Others Picture
Table Global Oncology Biosimilars Market Size (Volume) by Application
Figure Retail Pharmacies Picture
Figure Hospital Pharmacy Picture
Figure Online Pharmacy Picture
Table Global Oncology Biosimilars Comparison by Regions (M USD) 2016-2026
Figure Global Oncology Biosimilars Market Size (Million US$) (2016-2026)
Figure North America Oncology Biosimilars Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Oncology Biosimilars Revenue (Million US$) Growth Rate (2016-2026)
Figure Asia-pacific Oncology Biosimilars Revenue (Million US$) Growth Rate (2016-2026)
Figure South America Oncology Biosimilars Revenue (Million US$) Growth Rate (2016-2026)
Figure Middle East & Africa Oncology Biosimilars Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Oncology Biosimilars Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Oncology Biosimilars Sales by Manufacturer (2016-2021)
Figure Global Oncology Biosimilars Sales Market Share by Manufacturer in 2020
Table Global Oncology Biosimilars Revenue by Manufacturer (2016-2021)
Figure Global Oncology Biosimilars Revenue Market Share by Manufacturer in 2020
Table Global Oncology Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Oncology Biosimilars Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Oncology Biosimilars Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Oncology Biosimilars Market
Table Key Manufacturers Oncology Biosimilars Product Type
Table Mergers & Acquisitions Planning
Table Celltrion Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Celltrion
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Celltrion 2016-2021
Table Celltrion Main Business
Table Celltrion Recent Development
Table Teva Pharmaceutical Industries Ltd Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Teva Pharmaceutical Industries Ltd
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Teva Pharmaceutical Industries Ltd 2016-2021
Table Teva Pharmaceutical Industries Ltd Main Business
Table Teva Pharmaceutical Industries Ltd Recent Development
Table STADA Arzneimittel AG Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of STADA Arzneimittel AG
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of STADA Arzneimittel AG 2016-2021
Table STADA Arzneimittel AG Main Business
Table STADA Arzneimittel AG Recent Development
Table Biocon Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Biocon
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biocon 2016-2021
Table Biocon Main Business
Table Biocon Recent Development
Table Sandoz International Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Sandoz International
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sandoz International 2016-2021
Table Sandoz International Main Business
Table Sandoz International Recent Development
Table Dr. Reddy's Laboratories Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Dr. Reddy's Laboratories
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Dr. Reddy's Laboratories 2016-2021
Table Dr. Reddy's Laboratories Main Business
Table Dr. Reddy's Laboratories Recent Development
Table BIOCAD Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of BIOCAD
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of BIOCAD 2016-2021
Table BIOCAD Main Business
Table BIOCAD Recent Development
Table Pfizer Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Pfizer
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2016-2021
Table Pfizer Main Business
Table Pfizer Recent Development
Table Intas Pharmaceuticals Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Intas Pharmaceuticals
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Intas Pharmaceuticals 2016-2021
Table Intas Pharmaceuticals Main Business
Table Intas Pharmaceuticals Recent Development
Table Apotex Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Apotex
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Apotex 2016-2021
Table Apotex Main Business
Table Apotex Recent Development
Figure Global Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure Global Oncology Biosimilars Revenue and Growth Rate (2016-2021)
Table Global Oncology Biosimilars Sales by Regions (2016-2021)
Figure Global Oncology Biosimilars Sales Market Share by Regions in 2020
Table Global Oncology Biosimilars Revenue by Regions (2016-2021)
Figure Global Oncology Biosimilars Revenue Market Share by Regions in 2020
Figure North America Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure Europe Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure Asia-pacific Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure South America Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure Middle East & Africa Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure North America Oncology Biosimilars Revenue and Growth Rate (2016-2021)
Table North America Oncology Biosimilars Sales (Volume) by Countries (2016-2021)
Table North America Oncology Biosimilars Sales Market Share by Countries (2016-2021)
Figure North America Oncology Biosimilars Sales Market Share by Countries in 2020
Table North America Oncology Biosimilars Revenue by Countries (2016-2021)
Table North America Oncology Biosimilars Revenue Market Share by Countries (2016-2021)
Figure North America Oncology Biosimilars Revenue Market Share by Countries in 2020
Figure United States Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure Canada Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure Mexico Oncology Biosimilars Sales and Growth Rate (2016-2021)
Table North America Oncology Biosimilars Revenue by Manufacturer (2020)
Figure North America Oncology Biosimilars Revenue Market Share by Manufacturer in 2020
Table North America Oncology Biosimilars Sales by Type (2016-2021)
Table North America Oncology Biosimilars Sales Share by Type (2016-2021)
Table North America Oncology Biosimilars Sales by Application (2016-2021)
Table North America Oncology Biosimilars Sales Share by Application (2016-2021)
Figure Europe Oncology Biosimilars Revenue and Growth Rate (2016-2021)
Table Europe Oncology Biosimilars Sales (Volume) by Countries (2016-2021)
Table Europe Oncology Biosimilars Sales Market Share by Countries (2016-2021)
Figure Europe Oncology Biosimilars Sales Market Share by Countries in 2020
Table Europe Oncology Biosimilars Revenue by Countries (2016-2021)
Table Europe Oncology Biosimilars Revenue Market Share by Countries (2016-2021)
Figure Europe Oncology Biosimilars Revenue Market Share by Countries in 2020
Figure Germany Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure UK Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure France Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure Russia Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure Italy Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure Spain Oncology Biosimilars Sales and Growth Rate (2016-2021)
Table Europe Oncology Biosimilars Revenue by Manufacturer (2020)
Figure Europe Oncology Biosimilars Revenue Market Share by Manufacturer in 2020
Table Europe Oncology Biosimilars Sales by Type (2016-2021)
Table Europe Oncology Biosimilars Sales Share by Type (2016-2021)
Table Europe Oncology Biosimilars Sales by Application (2016-2021)
Table Europe Oncology Biosimilars Sales Share by Application (2016-2021)
Figure Asia-pacific Oncology Biosimilars Revenue and Growth Rate (2016-2021)
Table Asia-pacific Oncology Biosimilars Sales (Volume) by Countries (2016-2021)
Table Asia-pacific Oncology Biosimilars Sales Market Share by Countries (2016-2021)
Figure Asia-pacific Oncology Biosimilars Sales Market Share by Countries in 2020
Table Asia-pacific Oncology Biosimilars Revenue by Countries (2016-2021)
Table Asia-pacific Oncology Biosimilars Revenue Market Share by Countries (2016-2021)
Figure Asia-pacific Oncology Biosimilars Revenue Market Share by Countries in 2020
Figure China Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure South Korea Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure Japan Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure Australia Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure India Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure Southeast Asia Oncology Biosimilars Sales and Growth Rate (2016-2021)
Table Asia-pacific Oncology Biosimilars Revenue by Manufacturer (2020)
Figure Asia-pacific Oncology Biosimilars Revenue Market Share by Manufacturer in 2020
Table Asia-pacific Oncology Biosimilars Sales by Type (2016-2021)
Table Asia-pacific Oncology Biosimilars Sales Share by Type (2016-2021)
Table Asia-pacific Oncology Biosimilars Sales by Application (2016-2021)
Table Asia-pacific Oncology Biosimilars Sales Share by Application (2016-2021)
Figure South America Oncology Biosimilars Revenue and Growth Rate (2016-2021)
Table South America Oncology Biosimilars Sales (Volume) by Countries (2016-2021)
Table South America Oncology Biosimilars Sales Market Share by Countries (2016-2021)
Figure South America Oncology Biosimilars Sales Market Share by Countries in 2019
Table South America Oncology Biosimilars Revenue by Countries (2016-2021)
Table South America Oncology Biosimilars Revenue Market Share by Countries (2016-2021)
Figure South America Oncology Biosimilars Revenue Market Share by Countries in 2019
Figure Brazil Oncology Biosimilars Sales and Growth Rate (2016-2021)
Table South America Oncology Biosimilars Sales by Type (2016-2021)
Table South America Oncology Biosimilars Sales Share by Type (2016-2021)
Table South America Oncology Biosimilars Revenue by Type (2016-2021)
Table South America Oncology Biosimilars Revenue Share by Type (2016-2021)
Table South America Oncology Biosimilars Sales by Application (2016-2021)
Table South America Oncology Biosimilars Sales Share by Application (2016-2021)
Figure Middle East and Africa Oncology Biosimilars Revenue and Growth Rate (2016-2021)
Table Middle East and Africa Oncology Biosimilars Sales (Volume) by Countries (2016-2021)
Table Middle East and Africa Oncology Biosimilars Sales Market Share by Countries (2016-2021)
Figure Middle East and Africa Oncology Biosimilars Sales Market Share by Countries in 2019
Table Middle East and Africa Oncology Biosimilars Revenue by Countries (2016-2021)
Table Middle East and Africa Oncology Biosimilars Revenue Market Share by Countries (2016-2021)
Figure Middle East and Africa Oncology Biosimilars Revenue Market Share by Countries in 2019
Figure GCC Countries Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure Turkey Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure Egypt Oncology Biosimilars Sales and Growth Rate (2016-2021)
Figure South Africa Oncology Biosimilars Sales and Growth Rate (2016-2021)
Table Middle East and Africa Oncology Biosimilars Sales by Type (2016-2021)
Table Middle East and Africa Oncology Biosimilars Sales Share by Type (2016-2021)
Table Middle East and Africa Oncology Biosimilars Revenue by Type (2016-2021)
Table Middle East and Africa Oncology Biosimilars Revenue Share by Type (2016-2021)
Table Middle East and Africa Oncology Biosimilars Sales by Application (2016-2021)
Table Middle East and Africa Oncology Biosimilars Sales Share by Application (2016-2021)
Table Global Oncology Biosimilars Sales by Type (2016-2021)
Table Global Oncology Biosimilars Sales Market Share by Type (2016-2021)
Figure Global Oncology Biosimilars Sales Market Share by Type in 2020
Table Global Oncology Biosimilars Revenue by Type (2016-2021)
Table Global Oncology Biosimilars Revenue Market Share by Type (2016-2021)
Figure Global Oncology Biosimilars Revenue Market Share by Type in 2019
Figure Global mAb Sales Growth Rate (2016-2021)
Figure Global mAb Price (2016-2021)
Figure Global Immunomodulators Sales Growth Rate (2016-2021)
Figure Global Immunomodulators Price (2016-2021)
Figure Global Hematopoietic Agents Sales Growth Rate (2016-2021)
Figure Global Hematopoietic Agents Price (2016-2021)
Figure Global G-CSF Sales Growth Rate (2016-2021)
Figure Global G-CSF Price (2016-2021)
Figure Global Others Sales Growth Rate (2016-2021)
Figure Global Others Price (2016-2021)
Table Global Oncology Biosimilars Sales by Application (2016-2021)
Table Global Oncology Biosimilars Sales Market Share by Application (2016-2021)
Figure Global Oncology Biosimilars Sales Market Share by Application in 2020
Figure Global Retail Pharmacies Sales Growth Rate (2016-2021)
Figure Global Hospital Pharmacy Sales Growth Rate (2016-2021)
Figure Global Online Pharmacy Sales Growth Rate (2016-2021)
Figure Global Oncology Biosimilars Sales and Growth Rate (2021-2026)
Figure Global Oncology Biosimilars Revenue and Growth Rate (2021-2026)
Table Global Oncology Biosimilars Sales Forecast by Regions (2016-2021)
Table Global Oncology Biosimilars Market Share Forecast by Regions (2016-2021)
Figure North America Sales Oncology Biosimilars Market Forecast (2021-2026)
Figure Europe Sales Oncology Biosimilars Market Forecast (2021-2026)
Figure Asia-Pacific Sales Oncology Biosimilars Market Forecast (2021-2026)
Figure South America Sales Oncology Biosimilars Market Forecast (2021-2026)
Figure Middle East & Africa Sales Oncology Biosimilars Market Forecast (2021-2026)
Table Global Oncology Biosimilars Sales Forecast by Type (2021-2026)
Table Global Oncology Biosimilars Market Share Forecast by Type (2021-2026)
Table Global Oncology Biosimilars Sales Forecast by Application (2021-2026)
Table Global Oncology Biosimilars Market Share Forecast by Application (2021-2026)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List
Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 147
According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period.
The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
Global Biosimilar Drug Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 147
According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
Global Biosimilars Market Research Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 2680 Onwards Pages: 167
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 3280 Onwards Pages: 133
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 07-Dec-2023 Price: US 3380 Onwards Pages: 106
Market Overview of Global Biosimilars market:
According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years.
A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 3280 Onwards Pages: 134
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 2680 Onwards Pages: 160
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 16-Nov-2023 Price: US 3380 Onwards Pages: 103
Market Overview of Global Biosimilar Monoclonal Antibodies market:
According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
